Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors

Molecular and Cellular Biology

Volumn 28, Issue 20, 2008, Pages 6373-6383

  Haumaitre, Cécile ^a   Lenoir, Olivia ^a   Scharfmann, Raphaël ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; TRICHOSTATIN A;

ACETYLATION; ACINAR CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL THERAPY; CELL TYPE; DIABETES MELLITUS; EMBRYO; ENZYME ACTIVITY; FEMALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL;

ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; DOWN-REGULATION; ENZYME INHIBITORS; FEMALE; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; ISLETS OF LANGERHANS; NERVE TISSUE PROTEINS; PANCREAS; PANCREAS, EXOCRINE; PANCREATIC DUCTS; PANCREATIC POLYPEPTIDE-SECRETING CELLS; RATS; RATS, WISTAR; STEM CELLS; VALPROIC ACID;

EUKARYOTA; RATTUS;

EID: 53549088061     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00413-08     Document Type: Article

References (67)

1. Apelqvist, A., H. Li, L. Sommer, P. Beatus, D. J. Anderson, T. Honjo, M. Hrabe de Angelis, U. Lendahl, and H. Edlund. 1999. Notch signalling controls pancreatic cell differentiation. Nature 400:877-881.
2. Attali, M., V. Stetsyuk, A. Basmaciogullari, V. Aiello, M. A. Zanta-Boussif, B. Duvillie, and R. Scharfmann. 2007. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes 56:1248-1258.
3. Backs, J., and E. N. Olson. 2006. Control of cardiac growth by histone acetylation/deacetylation. Circ. Res. 98:15-24.
4. Bhushan, A., N. Itoh, S. Kato, J. P. Thiery, P. Czernichow, S. Bellusci, and R. Scharfmann. 2001. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 128:5109-5117.
5. Cano, D. A., S. Sekine, and M. Hebrok. 2006. Primary cilia deletion in pancreatic epithelial cells results in cyst formation and pancreatitis. Gastroenterology 131:1856-1869.
6. Chang, S., T. A. McKinsey, C. L. Zhang, J. A. Richardson, J. A. Hill, and E. N. Olson. 2004. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell. Biol. 24:8467-8476.
7. Chang, S., B. D. Young, S. Li, X. Qi, J. A. Richardson, and E. N. Olson. 2006. Histone deacetylase 7 maintains vascular integrity by repressing matrix metal-loproteinase 10. Cell 126:321-334.
8. Collombat, P., J. Hecks her-Sorens en, V. Broccoli, J. Krull, I. Ponte, T. Mundiger, J. Smith, P. Gruss, P. Serup, and A. Mansouri. 2005. The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas. Development 132:2969-2980.
9. Collombat, P., J. Hecksher-Sorensen, J. Krull, J. Berger, D. Riedel, P. L. Herrera, P. Serup, and A. Mansouri. 2007. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J. Clin. Investig. 117:961-970.
10. Collombat, P., J. Hecksher-Sorensen, P. Serup, and A. Mansouri. 2006. Specifying pancreatic endocrine cell fates. Mech. Dev. 123:501-512.
11. Collombat, P., A. Mansouri, J. Hecksher-Sorensen, P. Serup, J. Krull, G. Gradwohl, and P. Gruss. 2003. Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev. 17:2591-2603.
12. Cress, W. D., and E. Seto. 2000. Histone deacetylases, transcriptional control, and cancer. J. Cell Physiol. 184:1-16.
13. Davie, J. R. 2003. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133:2485S-2493S.
14. de Ruijter, A. J., A. H. van Gennip, H. N. Caron, S. Kemp, and A. B. van Kuilenburg. 2003. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370:737-749.
15. Duvillie, B., M. Attali, V. Aiello, E. Quemeneur, and R. Scharfmann. 2003. Label-retaining cells in the rat pancreas: location and differentiation potential in vitro. Diabetes 52:2035-2042.
16. Duvillie, B., M. Attali. A. Bounacer, P. Ravassard, A. Basmaciogullari, and R. Scharfmann. 2006. The mesenchyme controls the timing of pancreatic beta-cell differentiation. Diabetes 55:582-589.
17. Finnin, M. S., J. R. Donigian, A. Cohen, V. M. Richon, R. A. Rifkind, P. A. Marks, R. Breslow, and N. P. Pavletich. 1999. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401:188-193.
18. Gottlicher, M., S. Minucci, P. Zhu, O. H. Kramer, A. Schimpf, S. Giavara, J. P. Sleeman, F. Lo Coco, C. Nervi, P. G. Pelicci, and T. Heinzel. 2001. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20:6969-6978.
19. Gradwohl, G., A. Dierich, M. LeMeur, and F. Guillemot. 2000. neurogenic is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. USA 97:1607-1611.
20. Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389:349-352.
21. Gu, G., J. Dubauskaite, and D. A. Melton. 2002. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development. 129:2447-2457.
22. Guillemain, G., G. Filhoulaud, G. Da Silva-Xavier, G. A. Rutter, and R. Scharfmann. 2007. Glucose is necessary for embryonic pancreatic endocrine cell differentiation. J. Biol. Chem. 282:15228-15237.
23. Hald, J., J. P. Hjorth, M. S. German, O. D. Madsen, P. Serup, and J. Jensen. 2003. Activated Notchl prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev. Biol. 260:426-437.
24. Harmon, E. B., A. A. Apelqvist, N. G. Smart, X. Gu, D. H. Osborne, and S. K. Kim. 2004. GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development. Development 131:6163-6174.
25. Henseleit, K. D., S. B. Nelson, K. Kuhlbrodt, J. C. Hennings, J. Ericson, and M. Sander. 2005. NKX6 transcription factor activity is required for alpha-and beta-cell development in the pancreas. Development 132:3139-3149.
26. Hsieh, J., K. Nakashima, T. Kuwabara, E. Mejia, and F. H. Gage. 2004. Histone deacetylase inhibition-mediated neuronal differentiation of multi-potent adult neural progenitor cells. Proc. Natl. Acad. Sci. USA 101:16659-16664.
27. Hu, E., E. Dul, C. M. Sung, Z. Chen, R. Kirkpatrick, G. F. Zhang, K. Johanson, R. Liu, A. Lago, G. Hofmann, R. Macarron, M. de los Frailes, P. Perez, J. Krawiec, J. Winkler, and M. Jaye. 2003. Identification of novel isoform-selective inhibitors within class I histone deacetylases. J. Pharmacol. Exp. Ther. 307:720-728.
28. Huang, H. P., M. Liu, H. M. El-Hodiri, K. Chu, M. Jamrich, and M. J. Tsai. 2000. Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3. Mol. Cell. Biol. 20:3292-3307.
29. Johansson, K. A., U. Dursun, N. Jordan, G. Gu, F. Beermann, G. Gradwohl, and A. Grapin-Botton. 2007. Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev. Cell 12:457-465.
30. Jonsson, J., L. Carlsson, T. Edlund, and H. Edlund. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606-609.
31. Jorgensen, M. C., J. Ahnfelt-Ronne, J. Hald, O. D. Madsen, P. Serup, and J. Hecksher-Sorensen. 2007. An illustrated review of early pancreas development in the mouse. Endocr. Rev. 28:685-705.
32. Kilic, G., J. Wang, and B. Sosa-Pineda. 2006. Osteopontin is a novel marker of pancreatic ductal tissues and of undifferentiated pancreatic precursors in mice. Dev. Dyn. 235:1659-1667.
33. Kim, S. K., M. Hebrok, and D. A. Melton. 1997. Notochord to endoderm signaling is required for pancreas development. Development 124:4243-4252.
34. Krapp, A., M. Knofler, B. Ledermann, K. Burki, C. Berney, N. Zoerkler, O. Hagenbuchle, and P. K. Wellauer. 1998. The bHLH protein PTFl-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 12:3752-3763.
35. Kuo, M. H., and C. D. Allis. 1998. Roles of histone acetyl transferases and deacetylases in gene regulation. Bioessays 20:615-626.
36. Lagger, G., D. O'Carroll, M. Rembold, H. Khier, J. Tischler, G. Weitzer, B. Schuettengruber, C. Hauser, R. Brunmeir, T. Jenuwein, and C. Seiser. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21:2672-2681.
37. Lammert, E., O. Cleaver, and D. Melton. 2001. Induction of pancreatic differentiation by signals from blood vessels. Science 294:564-567.
38. Lee, H. W., J. H. Suh, A. Y. Kim, Y. S. Lee, S. Y. Park, and J. B. Kim. 2006. Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation. Mol. Endocrinol. 20:2432-2443.
39. -δδCT method. Methods 25:402-408.
40. Mariadason, J. M., G. A. Corner, and L. H. Augenlicht. 2000. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res. 60:4561-4572.
41. Marin-Husstege, M., M. Muggironi, A. Liu, and P. Casaccia-Bonnefil. 2002. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J. Neurosci. 22:10333-10345.
42. Marks, P. A., V. M. Richon, T. Miller, and W. K. Kelly. 2004. Histone deacetylase inhibitors. Adv. Cancer Res. 91:137-168.
43. Martin, M., R. Kettmann, and F. Dequiedt. 2007. Class IIa histone deacetylases: regulating the regulators. Oncogene 26:5450-5467.
44. McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11: 497-504.
45. Means, A. L., I. M. Meszoely, K. Suzuki, Y. Miyamoto, A. K. Rustgi, R. J. Coffey, Jr., C. V. Wright, D. A. Stoffers, and S. D. Leach. 2005. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 132:3767-3776.
46. Minucci, S., and P. G. Pelicci. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer. 6:38-51.
47. Miralles, F., T. Battelino, P. Czernichow, and R. Scharfmann. 1998. TGF-beta plays a key role in morphogenesis of the pancreatic islets of Langerhans by controlling the activity of the matrix metalloproteinase MMP-2. J. Cell Biol. 143:827-836.
48. Montgomery, R. L., C. A. Davis, M. J. Potthoff, M. Haberland, J. Fielitz, X. Qi, J. A. Hill, J. A. Richardson, and E. N. Olson. 2007. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 21:1790-1802.
49. Naya, F. J., H. P. Huang, Y. Qiu, H. Mutoh, F. J. DeMayo, A. B. Leiter, and M. J. Tsai. 1997. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 11:2323-2334.
50. Offield, M. F., T. L. Jetton, P. A. Labosky, M. Ray, R. W. Stein, M. A. Magnuson, B. L. Hogan, and C. V. Wright. 1996. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122:983-995.
51. Phiel, C. J., F. Zhang, E. Y. Huang, M. G. Guenther, M. A. Lazar, and P. S. Klein. 2001. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276:36734-36741.
52. Pierreux, C. E., A. V. Poll, C. R. Kemp, F. Clotman, M. A. Maestro, S. Cordi, J. Ferrer, L. Leyns, G. G. Rousseau, and F. P. Lemaigre. 2006. The transcription factor hepatocyte nuclear factor-6 controls the development of pancreatic ducts in the mouse. Gastroenterology 130:532-541.
53. Pin, C. L., J. M. Rukstalis, C. Johnson, and S. F. Konieczny. 2001. The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. J. Cell Biol. 155:519-530.
54. Scharfmann, R. 2000. Control of early development of the pancreas in rodents and humans: implications of signals from the mesenchyme. Dia-betologia 43:1083-1092.
55. Shen, S., J. Li, and P. Casaccia-Bonnefil. 2005. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J. Cell Biol. 169:577-589.
56. Sosa-Pineda, B., K. Chowdhury, M. Torres, G. Oliver, and P. Gruss. 1997. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 386:399-402.
57. Tao, R., E. F. de Zoeten, E. Ozkaynak, C. Chen, L. Wang, P. M. Porrett, B. Li, L. A. Turka, E. N. Olson, M. I. Greene, A. D. Wells, and W. W. Hancock. 2007. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13:1299-1307.
58. Tou, L., Q. Liu, and R. A. Shivdasani. 2004. Regulation of mammalian epithelial differentiation and intestine development by class I histone deacetylases. Mol. Cell. Biol. 24:3132-3139.
59. Trivedi, C. M., Y. Luo, Z. Yin, M. Zhang, W. Zhu, T. Wang, T. Floss, M. Goettlicher, P. R. Noppinger, W. Wurst, V. A. Ferrari, C. S. Abrams, P. J. Gruber, and J. A. Epstein. 2007. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat. Med. 13:324-331.
60. Van Lint, C., S. Emiliani, and E. Verdin. 1996. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5:245-253.
61. Vega, R. B., K. Matsuda, J. Oh, A. C. Barbosa, X. Yang, E. Meadows, J. McAnally, C. Pomajzl, J. M. Shelton, J. A. Richardson, G. Karsenty, and E. N. Olson. 2004. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119:555-566.
62. Xu, W. S., R. B. Parmigiani, and P. A. Marks. 2007. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26:5541-5552.
63. Yamaguchi, M., N. Tonou-Fujimori, A. Komori, R. Maeda, Y. Nojima, H. Li, H. Okamoto, and I. Masai. 2005. Histone deacetylase 1 regulates retinal neurogenesis in zebrafish by suppressing Wnt and Notch signaling pathways. Development 132:3027-3043.
64. Yang, X. J., and E. Seto. 2007. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26:5310-5318.
65. Yoo, E. J., J. J. Chung, S. S. Choe, K. H. Kim, and J. B. Kim. 2006. Down-regulation of histone deacetylases stimulates adipocyte differentiation. J. Biol. Chem. 281:6608-6615.
66. Yoshida, M., S. Horinouchi, and T. Beppu. 1995. Trichostatin A and trap-oxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17:423-430.
67. Yoshida, M., M. Kijima, M. Akita, and T. Beppu. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:17174-17179.